We are live on
!
Find out more
RGNCM
R.G. Niederhoffer Capital Management Portfolio holdings
AUM
$11.3M
This Fund
S&P 500
This Quarter
Est. Return
+4.38%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$24.5M
AUM Growth
–
Cap. Flow
+$25M
Cap. Flow
% of AUM
102.01%
Top 10 Holdings %
Top 10 Hldgs %
64.39%
Holding
25
New
25
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$2.08M |
| 2 |
Baidu
BIDU
|
+$2.01M |
| 3 |
Biogen
BIIB
|
+$1.94M |
| 4 |
Amgen
AMGN
|
+$1.82M |
| 5 |
Amazon
AMZN
|
+$1.67M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 37.69% |
| 2 | Communication Services | 26.97% |
| 3 | Consumer Discretionary | 13% |
| 4 | Technology | 9.86% |
| 5 | Financials | 3.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Gilead Sciences
GILD
$168B
| $1.88M | 7.66% |
+26,500
| New | +$2.08M |
|
|
2
Biogen
BIIB
$30.8B
| $1.87M | 7.61% |
+6,100
| New | +$1.94M |
|
|
3
Amgen
AMGN
$210B
| $1.85M | 7.55% |
+15,000
| New | +$1.82M |
|
|
FRX
4
DELISTED
FOREST LABORATORIES INC
FRX
| $1.85M | 7.53% |
+20,000
| New | +$1.61M |
|
|
5
Baidu
BIDU
$38.2B
| $1.83M | 7.46% |
+12,000
| New | +$2.01M |
|
6
Alphabet (Google) Class C
GOOG
$4.59T
| $1.56M | 6.37% |
+56,210
| New | +$1.64M |
|
|
7
Amazon
AMZN
$2.99T
| $1.51M | 6.18% |
+90,000
| New | +$1.67M |
|
8
Meta Platforms (Facebook)
META
$1.5T
| $1.36M | 5.56% |
+22,600
| New | +$1.43M |
|
9
Microsoft
MSFT
$3.66T
| $1.06M | 4.32% |
+25,800
| New | +$968K |
|
10
Netflix
NFLX
$306B
| $1.02M | 4.17% |
+203,000
| New | +$1.16M |
|
11
iShares US Real Estate ETF
IYR
$4.67B
| $982K | 4.01% |
+14,500
| New | +$962K |
|
12
Goldman Sachs
GS
$311B
| $902K | 3.68% |
+5,500
| New | +$925K |
|
13
Apple
AAPL
$4.52T
| $859K | 3.5% |
+44,800
| New | +$852K |
|
14
Starbucks
SBUX
$120B
| $837K | 3.41% |
+22,800
| New | +$843K |
|
15
Booking.com
BKNG
$151B
| $835K | 3.41% |
+17,500
| New | +$864K |
|
16
Pfizer
PFE
$145B
| $826K | 3.37% |
+27,088
| New | +$808K |
|
|
WBA
17
DELISTED
Walgreens Boots Alliance
WBA
| $621K | 2.53% |
+9,400
| New | +$591K |
|
18
Micron Technology
MU
$1.01T
| $500K | 2.04% |
+21,100
| New | +$501K |
|
19
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.2B
| $452K | 1.84% |
+1,800
| New | +$441K |
|
20
Walt Disney
DIS
$170B
| $441K | 1.8% |
+5,500
| New | +$426K |
|
21
Vodafone
VOD
$36.3B
| $398K | 1.62% |
+10,800
| New | +$416K |
|
22
Merck
MRK
$316B
| $352K | 1.44% |
+6,498
| New | +$336K |
|
23
State Street Health Care Select Sector SPDR ETF
XLV
$41.8B
| $246K | 1% |
+4,200
| New | +$242K |
|
24
Boeing
BA
$187B
| $239K | 0.98% |
+1,900
| New | +$248K |
|
25
Caterpillar
CAT
$404B
| $239K | 0.98% |
+2,400
| New | +$226K |
|
Similar funds
FCM
DCM
LAM
HCM
TG
PCP
SPCP
ICP
R.G. Niederhoffer Capital Management's Q1 2014 Portfolio in Review
Q1 2014 is the first quarter with a 13F filing on record for R.G. Niederhoffer Capital Management, which disclosed 25 positions worth $24.5M. Its ten largest holdings account for 64% of the portfolio.
Its largest position is Gilead Sciences: 26,500 shares worth $1.88M.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, followed by Communication Services and Consumer Discretionary.
- R.G. Niederhoffer Capital Management's largest Q1 2014 buy was Gilead Sciences: 26,500 shares worth $1.88M.
- R.G. Niederhoffer Capital Management's ten largest holdings make up 64% of its $24.5M portfolio in Q1 2014.
- R.G. Niederhoffer Capital Management disclosed 25 positions in Q1 2014, its first 13F filing on record.
Based on R.G. Niederhoffer Capital Management's 13F filing for Q1 2014, filed 29 Apr 2014.